Cambridge Healthtech Institute’s 8th Annual

Clinical Technology and Innovation

Disruptive Technologies for Data and Trial Management

February 20-21, 2019


Digital technology, mobile solutions, novel data collection modalities and integrative systems are becoming game-changing features of modern clinical trials. However, the adoption of novel technology solutions to improve overall outcomes and garner operational efficiencies has been slower than expected. Cambridge Healthtech Institute’s 8th Annual “Clinical Technology and Innovation” conference will feature a broad array of topics such as blockchain technology, machine learning, digital trends, and their adoption and implementation in clinical research. We are looking forward to hosting a practical and productive knowledge and experience exchange.


Arrive early and attend Part 1 (Tues-Wed): Sensors, Wearables and Digital Biomarkers in Clinical Trials


Wednesday, February 20 - Thursday, February 21 (Part 2 of SCOPE)

Bridging Luncheon Presentation (Sponsorship Opportunity Available)

NEXT-GENERATION CLINICAL TRIALS

The Hitchhiker's Guide to MountainView - A True Story About an Exciting Journey

Kirstin Holzapfel, Head, Clinical Data Process Technology, Data Sciences & Analytics, Bayer AG

Changing the Clinical Paradigm: Striving for End-to-End Automation

Pam Duffy, IT Lead, Core Clinical Solutions & Services, Pfizer

Virtual Trials: Strategy and Technology

Nina Spiller, Vice President, Clinical Management, Otsuka Pharmaceutical Companies

Revolutionizing Clinical Trial Design and Set-Up with Digital Data Flow

Rob DiCicco (Principal Consultant at TransCelerate Biopharma Inc

 

The Future of Healthcare: Humans and Machines Partnering for Better Outcomes

Emmanuel Fombu, MD, MBA, Director, Digital Health Solutions, Novartis

 

CO-PRESENTATION: Using Metrics and Visualizations to Change the Way We Work

Kevin Ott, Clinical Operations Data Analyst, Clinical Affairs, Cardiovascular Systems, Inc.

Kyle Christopherson, Director of Clinical Affairs, Cardiovascular Systems, Inc

BLOCKCHAIN: Gamechanger in Clinical Research?

Blockchain Opportunities for Patient Data Donation & Clinical Research

Munther Baara, MS, Head, New Clinical Paradigm, Pfizer

Blockchain’s Opportunity Today and Potential For The Future

Mal Postings, Vice President, Head of Innovation/Emerging Technologies & Chief Architect Research & Development Solutions, IQVIA

PANEL DISCUSSION: Blockchain in Clinical Research

Moderator: Ramzi Najm, Senior Associate, Waife & Associates

The most significant costs to clinical trials are in time and resources to insure the com-pleteness, accuracy and integrity of patient data.  Blockchain technology has the potential to transform and simplify the exchange of data among business partners in clinical re-search. Can blockchain solutions be applied to reduce the time to bring new biopharmaceu-tical products to market while reducing the cost of achieving that objective?  The presenta-tions and discussion will address this opportunity and the path to its implementation.

  • What is the realistic path for the adoption of innovations such as block chain for sponsors, sites and CROs?  
  • Do service providers (CROs) play a leading or trailing role in the facilitating for the industry and why?
  • Unlike EDC, block chain technology requires sites to take an active role rather than waiting for sponsors/CROs to deliver the capabilities; how does that impact adoption?
  • Thoughts on global adoption
  • Thoughts on business process implications and feasibility for transition

Luncheon Presentation (Sponsorship Opportunity Available)

PLENARY KEYNOTES

Monday Evening, Tuesday Morning, Wednesday Afternoon Plenary Keynotes Featuring:
 
SCOPE’s 2019 Participant Engagement Award, in Memory of Jerry Matczak
Empowering Humans to Own Their Own Data
Digital Trends That Are Changing the Healthcare Experience
Why Do We Need Caregivers in Clinical Trials; Exploring Real-life Applications in Engagement and Retention
Welcome, Pharma, to AI. Here’s What You Have Been Missing.
 
For more details on the Plenary Keynotes: www.scopesummit.com/keynotes
For more details on the Participant Engagement Award: www.scopesummit.com/participant-engagement-award

Arrive early and attend Part 1 (Tues-Wed): Sensors, Wearables and Digital Biomarkers in Clinical Trials


For more details on the conference, please contact:
Marina Filshtinsky

Executive Director, Conferences

Cambridge Healthtech Institute (CHI)

Phone: 781.972.5496
Email: mfilshtinsky@healthtech.com

 

For partnering and sponsorship information, please contact:

Companies A-O

Ilana Quigley

Senior Manager, Business Development

Cambridge Healthtech Institute (CHI)

Phone: 781.972.5457

Email: iquigley@healthtech.com

 

Companies P-Z

Patty Rose
Senior Manager, Business Development

Cambridge Healthtech Institute (CHI)

Phone: 781.972.1349
Email: prose@healthtech.com

Signature Sponsor

IQVIA


Premier Sponsors

Appian

Bioclinica_new

ClinicalInk

Covance

DrugDev

ERT

PRA Health Sciences

Praxis

Syneos Health

UBC

Veeva